Literature DB >> 28343407

What are the complications and emerging strategies for preventing depression following traumatic brain injury?

Melissa Jones1,2,3,4, Laura Acion3,5, Ricardo E Jorge2,3,4.   

Abstract

INTRODUCTION: Depression is a common and disabling complication of traumatic brain injury (TBI). The high rates of post-TBI depression (PTBID) make this condition an important candidate for selective preventive interventions. Areas covered: The authors recently reported on the efficacy of sertraline, a selective serotonin reuptake inhibitor (SSRI), for the prevention of new cases of depression in the first six months after TBI. The authors review this and other studies on preventive strategies in PTBID as ascertained from a PubMed and citation search. The potential complications and barriers to the implementation of pharmacological prevention in patients with TBI are also discussed. Expert commentary: The prevention of depression in patients with TBI has received little attention relative to other medical conditions. Future studies are needed to confirm the benefit of SSRIs and investigate other pharmacological and non-pharmacological interventions, including in special groups of patients at greater risk of developing PTBID.

Entities:  

Keywords:  SSRI; TBI; Traumatic brain injury; depression; depressive disorders; prevention; sertraline

Mesh:

Substances:

Year:  2017        PMID: 28343407     DOI: 10.1080/14737175.2017.1311788

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  2 in total

1.  Clinical outcomes following major trauma for patients with a diagnosis of depression: a large UK database analysis.

Authors:  Jamie Large; David N Naumann; Jodie Fellows; Clare Connor; Zubair Ahmed
Journal:  Trauma Surg Acute Care Open       Date:  2021-12-14

2.  Non-pharmacological interventions for depressive disorder in patients after traumatic brain injury: A protocol for a systematic review and network meta-analysis.

Authors:  Mingmin Xu; Yu Guo; Yulong Wei; Lu Wang; Xiumei Feng; Yue Chen; Jian Yan
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.